Respiri crosses off new milestones to deliver Wheezo to respiratory illness patients in U.S.

Respiri CEO Marjan Mikel joins Natalie Stoberman from the Proactive studios to share how the company's Wheezo medical device is optimizing how patients and physicians treat respiratory illnesses like wheeze, asthma and COPD.

Respiri is a global e-Health SaaS company with products including Wheezo, the respiriTM mobile app and Respiri health portal.